Black and Hispanic patients with MCC are more likely to have tumors on UV-protected sites, which is associated with better ...

The new WHO global strategic initiative encouraged countries to adopt digital health tools to support universal health coverage.

In patients with plaque psoriasis, family history and palmoplantar involvement were among the predictors of early super response to bimekizumab.

Concomitant IBD reduces disease control and treatment response among patients with PsA receiving biologic therapy.

Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Credit: Getty Images Clinical guidelines on the management of atopic eczema have been updated to reflect new and expanded medication approvals. An updated evidence- and consensus-based living ...

This is a comprehensive table of dermatology ICD-10 codes used by researchers and healthcare professionals and personnel – nurses, medical coders, physicians, et al. This table has been curated for ...

A doctor filling out a prescription form The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the ...

Because they are rare and can look like several other conditions, knuckle pads might not be as easily recognized as other hyperkeratotic or fibrous lesions. Familiarity with the risk factors and ...

Patients with cutaneous squamous cell carcinoma and immunosuppression were more likely to experience local recurrence, nodal involvement, metastasis, and disease-specific mortality than patients ...

A family history of malignancy is the only patient-specific factor associated with a significantly increased risk for cancer among patients with psoriatic disease treated with biologics vs topical ...

An up-to-date review for dermatologists on ocular manifestations of lichen planus (LP), lichen planus pigmentosus (LPP), and lichen planopilaris (LPL), as well as guidelines on when to refer patients ...